The global BCG Vaccine for Tuberculosis (TB) market size was valued at US$ 82.7 million in 2024 and is forecast to a readjusted size of USD 101 million by 2031 with a CAGR of 3.0% during review period.
BCG Vaccine for Tuberculosis (TB) provides immunity or protection against tuberculosis (TB). The vaccine may be given to persons at high risk of developing TB.
Key driver for the BCG vaccine market is the increasing prevalence of tuberculosis (TB) in various regions, especially in countries with lower healthcare resources. Rising TB cases have driven governments and global health organizations, like the World Health Organization (WHO), to actively promote TB vaccination programs to curb the spread of the disease. Efforts to increase BCG vaccine coverage in high-risk areas and the focus on reducing childhood TB have further propelled demand, creating a sustained need for vaccine supply and development.
A major challenge in the BCG vaccine market is the variability in its effectiveness, especially against pulmonary TB in adults. This inconsistency in protection levels has led to cautious adoption in some regions with lower TB rates. Moreover, the emergence of multi-drug-resistant TB strains complicates the market, as BCG is not effective against these resistant strains. These limitations emphasize the need for alternative vaccines or treatments, affecting the long-term outlook for BCG as a standalone solution in TB prevention.
This report is a detailed and comprehensive analysis for global BCG Vaccine for Tuberculosis (TB) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global BCG Vaccine for Tuberculosis (TB) market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2020-2031
Global BCG Vaccine for Tuberculosis (TB) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2020-2031
Global BCG Vaccine for Tuberculosis (TB) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2020-2031
Global BCG Vaccine for Tuberculosis (TB) market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for BCG Vaccine for Tuberculosis (TB)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global BCG Vaccine for Tuberculosis (TB) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Japan BCG Lab, China National Biotec, AJ Vaccines, Serum Institute of India, BioFarma, GSBPL, Biomed Lublin, Taj Pharmaceuticals, Ataulpho de Paiva, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Â鶹Դ´ Segmentation
BCG Vaccine for Tuberculosis (TB) market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Â鶹Դ´ segment by Type
Immune Type
Therapy Type
Â鶹Դ´ segment by Application
Hospitals
Clinics
Others
Major players covered
Merck
Japan BCG Lab
China National Biotec
AJ Vaccines
Serum Institute of India
BioFarma
GSBPL
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
ANLIS Malbran
Fundação Ataulpho de Paiva
BB-NCIPD
Torlakinstitut
±õ³Õ´¡°äÌý–ÂÓª²Ô²õ³Ù¾±³Ù³Ü³Ù±ðÌý´Ç´ÚÌý³Õ²¹³¦³¦¾±²Ô±ð²õÌý²¹²Ô»åÌý²Ñ±ð»å¾±³¦²¹±ôÌýµþ¾±´Ç±ô´Ç²µ¾±³¦²¹±ô²õ
Institut Pasteur de Tunis
Â鶹Դ´ segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe BCG Vaccine for Tuberculosis (TB) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of BCG Vaccine for Tuberculosis (TB), with price, sales quantity, revenue, and global market share of BCG Vaccine for Tuberculosis (TB) from 2020 to 2025.
Chapter 3, the BCG Vaccine for Tuberculosis (TB) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the BCG Vaccine for Tuberculosis (TB) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and BCG Vaccine for Tuberculosis (TB) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of BCG Vaccine for Tuberculosis (TB).
Chapter 14 and 15, to describe BCG Vaccine for Tuberculosis (TB) sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Â鶹Դ´ Overview
1.1 Product Overview and Scope
1.2 Â鶹Դ´ Estimation Caveats and Base Year
1.3 Â鶹Դ´ Analysis by Type
1.3.1 Overview: Global BCG Vaccine for Tuberculosis (TB) Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Immune Type
1.3.3 Therapy Type
1.4 Â鶹Դ´ Analysis by Application
1.4.1 Overview: Global BCG Vaccine for Tuberculosis (TB) Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Others
1.5 Global BCG Vaccine for Tuberculosis (TB) Â鶹Դ´ Size & Forecast
1.5.1 Global BCG Vaccine for Tuberculosis (TB) Consumption Value (2020 & 2024 & 2031)
1.5.2 Global BCG Vaccine for Tuberculosis (TB) Sales Quantity (2020-2031)
1.5.3 Global BCG Vaccine for Tuberculosis (TB) Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck BCG Vaccine for Tuberculosis (TB) Product and Services
2.1.4 Merck BCG Vaccine for Tuberculosis (TB) Sales Quantity, Average Price, Revenue, Gross Margin and Â鶹Դ´ Share (2020-2025)
2.1.5 Merck Recent Developments/Updates
2.2 Japan BCG Lab
2.2.1 Japan BCG Lab Details
2.2.2 Japan BCG Lab Major Business
2.2.3 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Product and Services
2.2.4 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Sales Quantity, Average Price, Revenue, Gross Margin and Â鶹Դ´ Share (2020-2025)
2.2.5 Japan BCG Lab Recent Developments/Updates
2.3 China National Biotec
2.3.1 China National Biotec Details
2.3.2 China National Biotec Major Business
2.3.3 China National Biotec BCG Vaccine for Tuberculosis (TB) Product and Services
2.3.4 China National Biotec BCG Vaccine for Tuberculosis (TB) Sales Quantity, Average Price, Revenue, Gross Margin and Â鶹Դ´ Share (2020-2025)
2.3.5 China National Biotec Recent Developments/Updates
2.4 AJ Vaccines
2.4.1 AJ Vaccines Details
2.4.2 AJ Vaccines Major Business
2.4.3 AJ Vaccines BCG Vaccine for Tuberculosis (TB) Product and Services
2.4.4 AJ Vaccines BCG Vaccine for Tuberculosis (TB) Sales Quantity, Average Price, Revenue, Gross Margin and Â鶹Դ´ Share (2020-2025)
2.4.5 AJ Vaccines Recent Developments/Updates
2.5 Serum Institute of India
2.5.1 Serum Institute of India Details
2.5.2 Serum Institute of India Major Business
2.5.3 Serum Institute of India BCG Vaccine for Tuberculosis (TB) Product and Services
2.5.4 Serum Institute of India BCG Vaccine for Tuberculosis (TB) Sales Quantity, Average Price, Revenue, Gross Margin and Â鶹Դ´ Share (2020-2025)
2.5.5 Serum Institute of India Recent Developments/Updates
2.6 BioFarma
2.6.1 BioFarma Details
2.6.2 BioFarma Major Business
2.6.3 BioFarma BCG Vaccine for Tuberculosis (TB) Product and Services
2.6.4 BioFarma BCG Vaccine for Tuberculosis (TB) Sales Quantity, Average Price, Revenue, Gross Margin and Â鶹Դ´ Share (2020-2025)
2.6.5 BioFarma Recent Developments/Updates
2.7 GSBPL
2.7.1 GSBPL Details
2.7.2 GSBPL Major Business
2.7.3 GSBPL BCG Vaccine for Tuberculosis (TB) Product and Services
2.7.4 GSBPL BCG Vaccine for Tuberculosis (TB) Sales Quantity, Average Price, Revenue, Gross Margin and Â鶹Դ´ Share (2020-2025)
2.7.5 GSBPL Recent Developments/Updates
2.8 Biomed Lublin
2.8.1 Biomed Lublin Details
2.8.2 Biomed Lublin Major Business
2.8.3 Biomed Lublin BCG Vaccine for Tuberculosis (TB) Product and Services
2.8.4 Biomed Lublin BCG Vaccine for Tuberculosis (TB) Sales Quantity, Average Price, Revenue, Gross Margin and Â鶹Դ´ Share (2020-2025)
2.8.5 Biomed Lublin Recent Developments/Updates
2.9 Taj Pharmaceuticals
2.9.1 Taj Pharmaceuticals Details
2.9.2 Taj Pharmaceuticals Major Business
2.9.3 Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Product and Services
2.9.4 Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Sales Quantity, Average Price, Revenue, Gross Margin and Â鶹Դ´ Share (2020-2025)
2.9.5 Taj Pharmaceuticals Recent Developments/Updates
2.10 Ataulpho de Paiva
2.10.1 Ataulpho de Paiva Details
2.10.2 Ataulpho de Paiva Major Business
2.10.3 Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Product and Services
2.10.4 Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Sales Quantity, Average Price, Revenue, Gross Margin and Â鶹Դ´ Share (2020-2025)
2.10.5 Ataulpho de Paiva Recent Developments/Updates
2.11 ANLIS Malbran
2.11.1 ANLIS Malbran Details
2.11.2 ANLIS Malbran Major Business
2.11.3 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Product and Services
2.11.4 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Sales Quantity, Average Price, Revenue, Gross Margin and Â鶹Դ´ Share (2020-2025)
2.11.5 ANLIS Malbran Recent Developments/Updates
2.12 Fundação Ataulpho de Paiva
2.12.1 Fundação Ataulpho de Paiva Details
2.12.2 Fundação Ataulpho de Paiva Major Business
2.12.3 Fundação Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Product and Services
2.12.4 Fundação Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Sales Quantity, Average Price, Revenue, Gross Margin and Â鶹Դ´ Share (2020-2025)
2.12.5 Fundação Ataulpho de Paiva Recent Developments/Updates
2.13 BB-NCIPD
2.13.1 BB-NCIPD Details
2.13.2 BB-NCIPD Major Business
2.13.3 BB-NCIPD BCG Vaccine for Tuberculosis (TB) Product and Services
2.13.4 BB-NCIPD BCG Vaccine for Tuberculosis (TB) Sales Quantity, Average Price, Revenue, Gross Margin and Â鶹Դ´ Share (2020-2025)
2.13.5 BB-NCIPD Recent Developments/Updates
2.14 Torlakinstitut
2.14.1 Torlakinstitut Details
2.14.2 Torlakinstitut Major Business
2.14.3 Torlakinstitut BCG Vaccine for Tuberculosis (TB) Product and Services
2.14.4 Torlakinstitut BCG Vaccine for Tuberculosis (TB) Sales Quantity, Average Price, Revenue, Gross Margin and Â鶹Դ´ Share (2020-2025)
2.14.5 Torlakinstitut Recent Developments/Updates
2.15 ±õ³Õ´¡°äÌý–ÂÓª²Ô²õ³Ù¾±³Ù³Ü³Ù±ðÌý´Ç´ÚÌý³Õ²¹³¦³¦¾±²Ô±ð²õÌý²¹²Ô»åÌý²Ñ±ð»å¾±³¦²¹±ôÌýµþ¾±´Ç±ô´Ç²µ¾±³¦²¹±ô²õ
2.15.1 ±õ³Õ´¡°äÌý–ÂÓª²Ô²õ³Ù¾±³Ù³Ü³Ù±ðÌý´Ç´ÚÌý³Õ²¹³¦³¦¾±²Ô±ð²õÌý²¹²Ô»åÌý²Ñ±ð»å¾±³¦²¹±ôÌýµþ¾±´Ç±ô´Ç²µ¾±³¦²¹±ô²õ Details
2.15.2 ±õ³Õ´¡°äÌý–ÂÓª²Ô²õ³Ù¾±³Ù³Ü³Ù±ðÌý´Ç´ÚÌý³Õ²¹³¦³¦¾±²Ô±ð²õÌý²¹²Ô»åÌý²Ñ±ð»å¾±³¦²¹±ôÌýµþ¾±´Ç±ô´Ç²µ¾±³¦²¹±ô²õ Major Business
2.15.3 ±õ³Õ´¡°äÌý–ÂÓª²Ô²õ³Ù¾±³Ù³Ü³Ù±ðÌý´Ç´ÚÌý³Õ²¹³¦³¦¾±²Ô±ð²õÌý²¹²Ô»åÌý²Ñ±ð»å¾±³¦²¹±ôÌýµþ¾±´Ç±ô´Ç²µ¾±³¦²¹±ô²õ BCG Vaccine for Tuberculosis (TB) Product and Services
2.15.4 ±õ³Õ´¡°äÌý–ÂÓª²Ô²õ³Ù¾±³Ù³Ü³Ù±ðÌý´Ç´ÚÌý³Õ²¹³¦³¦¾±²Ô±ð²õÌý²¹²Ô»åÌý²Ñ±ð»å¾±³¦²¹±ôÌýµþ¾±´Ç±ô´Ç²µ¾±³¦²¹±ô²õ BCG Vaccine for Tuberculosis (TB) Sales Quantity, Average Price, Revenue, Gross Margin and Â鶹Դ´ Share (2020-2025)
2.15.5 ±õ³Õ´¡°äÌý–ÂÓª²Ô²õ³Ù¾±³Ù³Ü³Ù±ðÌý´Ç´ÚÌý³Õ²¹³¦³¦¾±²Ô±ð²õÌý²¹²Ô»åÌý²Ñ±ð»å¾±³¦²¹±ôÌýµþ¾±´Ç±ô´Ç²µ¾±³¦²¹±ô²õ Recent Developments/Updates
2.16 Institut Pasteur de Tunis
2.16.1 Institut Pasteur de Tunis Details
2.16.2 Institut Pasteur de Tunis Major Business
2.16.3 Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Product and Services
2.16.4 Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Sales Quantity, Average Price, Revenue, Gross Margin and Â鶹Դ´ Share (2020-2025)
2.16.5 Institut Pasteur de Tunis Recent Developments/Updates
3 Competitive Environment: BCG Vaccine for Tuberculosis (TB) by Manufacturer
3.1 Global BCG Vaccine for Tuberculosis (TB) Sales Quantity by Manufacturer (2020-2025)
3.2 Global BCG Vaccine for Tuberculosis (TB) Revenue by Manufacturer (2020-2025)
3.3 Global BCG Vaccine for Tuberculosis (TB) Average Price by Manufacturer (2020-2025)
3.4 Â鶹Դ´ Share Analysis (2024)
3.4.1 Producer Shipments of BCG Vaccine for Tuberculosis (TB) by Manufacturer Revenue ($MM) and Â鶹Դ´ Share (%): 2024
3.4.2 Top 3 BCG Vaccine for Tuberculosis (TB) Manufacturer Â鶹Դ´ Share in 2024
3.4.3 Top 6 BCG Vaccine for Tuberculosis (TB) Manufacturer Â鶹Դ´ Share in 2024
3.5 BCG Vaccine for Tuberculosis (TB) Â鶹Դ´: Overall Company Footprint Analysis
3.5.1 BCG Vaccine for Tuberculosis (TB) Â鶹Դ´: Region Footprint
3.5.2 BCG Vaccine for Tuberculosis (TB) Â鶹Դ´: Company Product Type Footprint
3.5.3 BCG Vaccine for Tuberculosis (TB) Â鶹Դ´: Company Product Application Footprint
3.6 New Â鶹Դ´ Entrants and Barriers to Â鶹Դ´ Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global BCG Vaccine for Tuberculosis (TB) Â鶹Դ´ Size by Region
4.1.1 Global BCG Vaccine for Tuberculosis (TB) Sales Quantity by Region (2020-2031)
4.1.2 Global BCG Vaccine for Tuberculosis (TB) Consumption Value by Region (2020-2031)
4.1.3 Global BCG Vaccine for Tuberculosis (TB) Average Price by Region (2020-2031)
4.2 North America BCG Vaccine for Tuberculosis (TB) Consumption Value (2020-2031)
4.3 Europe BCG Vaccine for Tuberculosis (TB) Consumption Value (2020-2031)
4.4 Asia-Pacific BCG Vaccine for Tuberculosis (TB) Consumption Value (2020-2031)
4.5 South America BCG Vaccine for Tuberculosis (TB) Consumption Value (2020-2031)
4.6 Middle East & Africa BCG Vaccine for Tuberculosis (TB) Consumption Value (2020-2031)
5 Â鶹Դ´ Segment by Type
5.1 Global BCG Vaccine for Tuberculosis (TB) Sales Quantity by Type (2020-2031)
5.2 Global BCG Vaccine for Tuberculosis (TB) Consumption Value by Type (2020-2031)
5.3 Global BCG Vaccine for Tuberculosis (TB) Average Price by Type (2020-2031)
6 Â鶹Դ´ Segment by Application
6.1 Global BCG Vaccine for Tuberculosis (TB) Sales Quantity by Application (2020-2031)
6.2 Global BCG Vaccine for Tuberculosis (TB) Consumption Value by Application (2020-2031)
6.3 Global BCG Vaccine for Tuberculosis (TB) Average Price by Application (2020-2031)
7 North America
7.1 North America BCG Vaccine for Tuberculosis (TB) Sales Quantity by Type (2020-2031)
7.2 North America BCG Vaccine for Tuberculosis (TB) Sales Quantity by Application (2020-2031)
7.3 North America BCG Vaccine for Tuberculosis (TB) Â鶹Դ´ Size by Country
7.3.1 North America BCG Vaccine for Tuberculosis (TB) Sales Quantity by Country (2020-2031)
7.3.2 North America BCG Vaccine for Tuberculosis (TB) Consumption Value by Country (2020-2031)
7.3.3 United States Â鶹Դ´ Size and Forecast (2020-2031)
7.3.4 Canada Â鶹Դ´ Size and Forecast (2020-2031)
7.3.5 Mexico Â鶹Դ´ Size and Forecast (2020-2031)
8 Europe
8.1 Europe BCG Vaccine for Tuberculosis (TB) Sales Quantity by Type (2020-2031)
8.2 Europe BCG Vaccine for Tuberculosis (TB) Sales Quantity by Application (2020-2031)
8.3 Europe BCG Vaccine for Tuberculosis (TB) Â鶹Դ´ Size by Country
8.3.1 Europe BCG Vaccine for Tuberculosis (TB) Sales Quantity by Country (2020-2031)
8.3.2 Europe BCG Vaccine for Tuberculosis (TB) Consumption Value by Country (2020-2031)
8.3.3 Germany Â鶹Դ´ Size and Forecast (2020-2031)
8.3.4 France Â鶹Դ´ Size and Forecast (2020-2031)
8.3.5 United Kingdom Â鶹Դ´ Size and Forecast (2020-2031)
8.3.6 Russia Â鶹Դ´ Size and Forecast (2020-2031)
8.3.7 Italy Â鶹Դ´ Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific BCG Vaccine for Tuberculosis (TB) Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific BCG Vaccine for Tuberculosis (TB) Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific BCG Vaccine for Tuberculosis (TB) Â鶹Դ´ Size by Region
9.3.1 Asia-Pacific BCG Vaccine for Tuberculosis (TB) Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific BCG Vaccine for Tuberculosis (TB) Consumption Value by Region (2020-2031)
9.3.3 China Â鶹Դ´ Size and Forecast (2020-2031)
9.3.4 Japan Â鶹Դ´ Size and Forecast (2020-2031)
9.3.5 South Korea Â鶹Դ´ Size and Forecast (2020-2031)
9.3.6 India Â鶹Դ´ Size and Forecast (2020-2031)
9.3.7 Southeast Asia Â鶹Դ´ Size and Forecast (2020-2031)
9.3.8 Australia Â鶹Դ´ Size and Forecast (2020-2031)
10 South America
10.1 South America BCG Vaccine for Tuberculosis (TB) Sales Quantity by Type (2020-2031)
10.2 South America BCG Vaccine for Tuberculosis (TB) Sales Quantity by Application (2020-2031)
10.3 South America BCG Vaccine for Tuberculosis (TB) Â鶹Դ´ Size by Country
10.3.1 South America BCG Vaccine for Tuberculosis (TB) Sales Quantity by Country (2020-2031)
10.3.2 South America BCG Vaccine for Tuberculosis (TB) Consumption Value by Country (2020-2031)
10.3.3 Brazil Â鶹Դ´ Size and Forecast (2020-2031)
10.3.4 Argentina Â鶹Դ´ Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa BCG Vaccine for Tuberculosis (TB) Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa BCG Vaccine for Tuberculosis (TB) Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa BCG Vaccine for Tuberculosis (TB) Â鶹Դ´ Size by Country
11.3.1 Middle East & Africa BCG Vaccine for Tuberculosis (TB) Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa BCG Vaccine for Tuberculosis (TB) Consumption Value by Country (2020-2031)
11.3.3 Turkey Â鶹Դ´ Size and Forecast (2020-2031)
11.3.4 Egypt Â鶹Դ´ Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Â鶹Դ´ Size and Forecast (2020-2031)
11.3.6 South Africa Â鶹Դ´ Size and Forecast (2020-2031)
12 Â鶹Դ´ Dynamics
12.1 BCG Vaccine for Tuberculosis (TB) Â鶹Դ´ Drivers
12.2 BCG Vaccine for Tuberculosis (TB) Â鶹Դ´ Restraints
12.3 BCG Vaccine for Tuberculosis (TB) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of BCG Vaccine for Tuberculosis (TB) and Key Manufacturers
13.2 Manufacturing Costs Percentage of BCG Vaccine for Tuberculosis (TB)
13.3 BCG Vaccine for Tuberculosis (TB) Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 BCG Vaccine for Tuberculosis (TB) Typical Distributors
14.3 BCG Vaccine for Tuberculosis (TB) Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Merck
Japan BCG Lab
China National Biotec
AJ Vaccines
Serum Institute of India
BioFarma
GSBPL
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
ANLIS Malbran
Fundação Ataulpho de Paiva
BB-NCIPD
Torlakinstitut
±õ³Õ´¡°äÌý–ÂÓª²Ô²õ³Ù¾±³Ù³Ü³Ù±ðÌý´Ç´ÚÌý³Õ²¹³¦³¦¾±²Ô±ð²õÌý²¹²Ô»åÌý²Ñ±ð»å¾±³¦²¹±ôÌýµþ¾±´Ç±ô´Ç²µ¾±³¦²¹±ô²õ
Institut Pasteur de Tunis
Ìý
Ìý
*If Applicable.
